This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Jeonghoon Han
Vice President, Chief Technology Officer, Head of R&D Center at EUTILEX, South Korea


Dr Jeonghoon Han graduated from University of Medicine & Dentistry in New Jersey with Ph.D. degree with his research interest in apoptosis, especially in cancer field. In 1999, he was a research fellow in Dana Farber Cancer Institute in Harvard Medical School for two years. He changed his career from oncology research to medical affairs and marketing in multi-national pharmaceutical companies (Eli Lilly, AstraZenca, BMS, Boehringer Ingelheim, Mundipharma, Teva, Amgen).

With the seven years’ experience of basic and translational researchs in academy and the eighteen years’ experiences of medical affairs and marketing in seven multinational pharmaceutical companies, he established the strong foundation of building competitive R&D and medical affairs’ strategies for developing differentiated pipelines in terms of global regulatory approval and commercial success.

Agenda Sessions

  • Introduction of Innovative T cell Therapies: 4-1BB Based Autologous T cell Therapy and MVR CAR-T

  • Discussion Panel: Outsourcing vs. Insourcing – What is the best path to take?